SCHEDULE 13G/A: OrbiMed Funds Update Significant Stake in InspireMD, Inc. to 7.2%
Beneficial Ownership Amendment
OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC have filed an Amendment No. 2 to their Schedule 13G, disclosing a combined beneficial ownership of 7.2% of InspireMD, Inc.'s common stock as of March 31, 2025.
Summary
- OrbiMed Advisors LLC reported beneficial ownership of 2,133,405 shares of InspireMD, Inc. common stock, representing 7.2% of the class.
- OrbiMed Capital GP IX LLC reported beneficial ownership of 1,878,704 shares of InspireMD, Inc. common stock, representing 6.3% of the class.
- Both OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC exercise shared voting and shared dispositive power over their respective reported shares.
- The filing is an Amendment No. 2 to a previously filed Schedule 13G, indicating an update to their beneficial ownership.
- The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of InspireMD, Inc.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of beneficial ownership and does not contain information that would significantly alter the company's operational or financial outlook, thus maintaining a neutral sentiment.
Positives
- The continued significant holding by OrbiMed, a prominent healthcare-focused investment firm, may signal ongoing institutional confidence in InspireMD, Inc.
Future Outlook
This document is a beneficial ownership disclosure and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
OrbiMed is a leading investment firm focused on the healthcare sector. Their continued significant stake in InspireMD, Inc., a company in the medical device space, aligns with broader trends of institutional investment in specialized healthcare and biotechnology companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional holdings in the company's common stock.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement. |
| 05/15/2025 | Date of execution and filing of the Joint Filing Agreement and Schedule 13G/A. |
Keywords
InspireMD Inc., OrbiMed Advisors LLC, OrbiMed Capital GP IX LLC, Schedule 13G/A, beneficial ownership, common stock, institutional investment, healthcare investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.